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Glycated haemoglobin has been widely accepted as a valuable indicator of diabetic control.' The proportion of glycated haemoglobin after removal of the labile glycated haemoglobin fraction correlates with the long-term control of blood glucose, but is also affected by red cell survival.
In addition, in uraemia, an apparent elevation of glycated haemoglobin has been found. This has been attributed to the presence of carbamylated haemoglobin which is formed by the reaction of cyanate derived from urea with the N-terminal amino group of haemoglobin. Carbamylated haemoglobin is co-eluted with glycated haemoglobin in cation exchange chromatography.2-5 When glycated haemoglobin is measured by a chemical method using thiobarbituric acid, carbamylated haemoglobin interference is absent .2-5 The carbamylated haemoglobin effect had not been reported with the electroendosmosis method used in our laboratory to measure stable glycated haemoglobin. A study to measure glycated haemoglobin in patients with varying degrees of renal failure and diabetic control was carried out to validate its usefulness in patients with chronic renal failure. variation) at 8% glycated haemoglobin and 2.2% at 13.8% glycated haemoglobin. Plasma glucose was measured in fluoride oxalate samples by a hexokinase/glucose-6-phosphate dehydrogenase method (Boehringer Ltd, Sussex, UK) on a Centrifichem 500 centrifugal analyser (Baker Instruments Ltd, Berkshire, UK). Fasting plasma glucose was used to distinguish between diabetic and non-diabetic subjects, and random plasma glucose were used to assess diabetic subgroups in terms of control (see below). Urea and electrolytes were measured on an Astra 4 Analyser (Beckman, High Wycombe, UK).
METHODS
Diabetic and non-diabetic patients with varying degree of renal failure and diabetic control who attended the renal unit of St Paul's Hospital during a period of 2 years were included in the study.
The subclassified according to their degree of renal failure into Bl-B4 and CI-C4. The glucose levels were mean values from at least three sets of random plasma glucose (over five values in 40% of cases) in the 6-8 week period during which glycated haemoglobin was measured.
Patients on dialysis were excluded from the study because of their rapidly changing plasma urea results. Patients were excluded from the study if they had less than three random glucose results in 6-8 weeks' study period, or their urea values varied by more than 5 mmol/L. One hundred and sixty-nine patient results satisfied the above criteria. Statistical comparison between subgroups were carried out using the unpaired t test.
RESULTS
Results from groups of diabetic and non-diabetic renal patients are shown in Table 1 . For the whole study, the glycated haemoglobin ( y ) results correlated well with mean glucose values (x), correlation coefficient 0.735, y=O-46x+ 5-01, P = <0.001 (graph not shown). The correlation of glycated haemoglobin with urea and creatinine was not significant.
The results in the group with normal glucose and urea values (Al) are similar to our established reference range ( 5 4 % ) . Glycated haemoglobin values in the non-diabetic patients with plasma urea concentrations > 25 -0 mmol/L (A4) were significantly higher than those with renal urea concentrations (Al) (P=O-001) . The values in those with lesser degrees of uraemia (A2 and A3) did not differ from A l .
The glycated haemoglobin results were, as expected, higher in each diabetic group than in the non-diabetic group with similar renal function.
In contrast to the non-diabetics, in the two diabetic subgroups there were no significant differences between glycated haemoglobin values in patients with normal urea and high urea concentrations. 
DISCUSSION
Using the Corning electroendosmosis method we found a small but significant increase in glycated haemoglobin only in non-diabetic patients with plasma urea concentrations over 25 mmol/L. Thus, glycated haemoglobin is a valid index of diabetic control in patients with chronic renal failure when the plasma urea level is below 25 mmol/L. The lack of significant effect of high urea levels in the diabetic subjects may partly be due to a greater role of glucose in raising glycated haemoglobin than of urea in forming carbamylated haemoglobin, so that the increased glycated haemoglobin masks the increase in carbamylated haemoglobin. Alternatively, an increase in glucose or glycated haemoglobin may inhibit carbamylated haemoglobin formation. Caution is required in interpreting glycated haemoglobin in diabetic patients with plasma urea concentrations above 25 mmol/L.
